Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 124
Filter
Add more filters

Publication year range
1.
Einstein (Sao Paulo) ; 18: eGS5129, 2020.
Article in English, Portuguese | MEDLINE | ID: mdl-31939526

ABSTRACT

OBJECTIVE: Economic evaluation of a scientific advisory program with the Public Defenders Office to mitigate the impacts of the judicialization on health in the municipality, as well as the implementation of an active follow-up program to monitor health outcomes arising from court demands. METHODS: A two-step study, the first documental, retrospective, with data collection of lawsuits in the region of Barbalha (CE), Brazil, from 2013 to 2018, and the second stage, prospective and intervention, through mediation between the citizen and the Public Defenders Office, aiming to reduce the occurrence of the judicialization, and the monitoring of the health outcomes of the processes. The study adopted the Consolidated Health Economic Evaluation Reporting Standards protocol for economic health assessments. The data obtained from the processes were grouped and treated for characterization of the scenario. A comparison of the profile of the lawsuits in the period of 12 months before and after the installation of the program to delimit a complete fiscal cycle was carried out. RESULTS: The advisory service promoted a decrease of 40% (p=0.01) in lawsuits. There was a 31% reduction in court costs (p=0.003), with medicines accounting for 33% of this amount. There was a decrease in inputs outside the Sistema Único de Saúde lists (27%; p=0.003), however there was no statistical difference among several demanding groups, suggesting an equanimous approach. CONCLUSION: Data from the initial survey were comparable to those reported in Brazil regarding the profile of judicial demands. In view of the scenario, the proposal proved feasible as a means to mitigate the costs of the judicialization through mediation. Finally, the initiative can serve as a model for adoption by municipalities that have characteristics similar to those presented in this study.


Subject(s)
Health Services Accessibility/legislation & jurisprudence , Health Services Needs and Demand/legislation & jurisprudence , Judicial Role , Brazil , Cities , Health Care Costs/legislation & jurisprudence , Health Services Accessibility/economics , Health Services Needs and Demand/economics , Humans , National Health Programs/legislation & jurisprudence , Outcome Assessment, Health Care , Retrospective Studies , Socioeconomic Factors
2.
Pediatrics ; 145(1)2020 01.
Article in English | MEDLINE | ID: mdl-31888959

ABSTRACT

CONTEXT: Integrated care models may improve health care for children and young people (CYP) with ongoing conditions. OBJECTIVE: To assess the effects of integrated care on child health, health service use, health care quality, school absenteeism, and costs for CYP with ongoing conditions. DATA SOURCES: Medline, Embase, PsycINFO, Cumulative Index to Nursing and Allied Health Literature, and the Cochrane Library databases (1996-2018). STUDY SELECTION: Inclusion criteria consisted of (1) randomized controlled trials, (2) evaluating an integrated care intervention, (3) for CYP (0-18 years) with an ongoing health condition, and (4) including at least 1 health-related outcome. DATA EXTRACTION: Descriptive data were synthesized. Data for quality of life (QoL) and emergency department (ED) visits allowed meta-analyses to explore the effects of integrated care compared to usual care. RESULTS: Twenty-three trials were identified, describing 18 interventions. Compared with usual care, integrated care reported greater cost savings (3/4 studies). Meta-analyses found that integrated care improved QoL over usual care (standard mean difference = 0.24; 95% confidence interval = 0.03-0.44; P = .02), but no significant difference was found between groups for ED visits (odds ratio = 0.88; 95% confidence interval = 0.57-1.37; P = .57). LIMITATIONS: Included studies had variable quality of intervention, trial design, and reporting. Randomized controlled trials only were included, but valuable data from other study designs may exist. CONCLUSIONS: Integrated care for CYP with ongoing conditions may deliver improved QoL and cost savings. The effects of integrated care on outcomes including ED visits is unclear.


Subject(s)
Adolescent Health Services , Child Health Services , Delivery of Health Care, Integrated , Health Services Needs and Demand , Quality of Health Care , Absenteeism , Adolescent , Adolescent Health Services/economics , Adolescent Health Services/standards , Adolescent Health Services/statistics & numerical data , Asthma/therapy , Child , Child Health , Child Health Services/economics , Child Health Services/standards , Child Health Services/statistics & numerical data , Child, Preschool , Confidence Intervals , Cost Savings , Cost-Benefit Analysis , Delivery of Health Care, Integrated/economics , Delivery of Health Care, Integrated/standards , Delivery of Health Care, Integrated/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Health Care Costs , Health Services Needs and Demand/economics , Health Services Needs and Demand/standards , Health Services Needs and Demand/statistics & numerical data , Humans , Infant , Infant, Newborn , Quality of Life , Randomized Controlled Trials as Topic , Treatment Outcome
3.
J Aging Soc Policy ; 32(1): 55-82, 2020.
Article in English | MEDLINE | ID: mdl-30929585

ABSTRACT

Social innovations in long-term care (LTC) may be useful in more effective responses to the challenges of population aging for Western societies. One of the most investigated aspects in this regard is the role of family/informal care and strategies to improve its integration into the formal care system, yielding a more holistic care approach that may enhance opportunities for aging in place. This article reports the findings of a comparative research focusing on the Italian and Israeli LTC systems as representative of the Mediterranean "family-based" care model. To analyze the innovative solutions that have been adopted or are needed to improve LTC provision in these two contexts, focus groups and expert interviews have been carried out in both countries to identify the most relevant challenges and responses to them and to highlight promising policies and strategies to be adopted or up-scaled in the future. These include multidisciplinary case and care management, a stronger connection between prevention and LTC provision, and more systematic recognition of the role and limits of informal caregivers' contributions.


Subject(s)
Caregivers , Health Services Needs and Demand/trends , Health Services for the Aged/trends , Long-Term Care/trends , Aged , Focus Groups , Frail Elderly , Health Policy , Health Services Needs and Demand/economics , Health Services for the Aged/economics , Humans , Interviews as Topic , Israel , Italy , Long-Term Care/economics , Qualitative Research , Social Welfare , State Medicine
4.
Einstein (Sao Paulo) ; 18: eGS4442, 2020.
Article in English, Portuguese | MEDLINE | ID: mdl-31576910

ABSTRACT

OBJECTIVE: To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease. METHODS: We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center. RESULTS: Public interest civil action and ordinary procedures, among others, were the most common used by the patients to obtain the medicine. Two Health Centers in Paraná (Londrina and Umuarama) concentrated more than 50% of the actions. The most common specialty of physicians who prescribed (33.8%) was pulmonology. There is a small financial impact of tiotropium bromide on general costs with medicines of the Paraná State Drug Center. However, a significant individual financial impact was observed because one unit of the medicine represents 38% of the Brazilian minimum wage. CONCLUSION: Our study highlights the need of incorporating this medicine in the class of long-acting anticholinergic bronchodilator in the Brazilian public health system.


Subject(s)
Bronchodilator Agents/economics , Drugs, Essential/supply & distribution , Health Services Needs and Demand/legislation & jurisprudence , Judicial Role , Pulmonary Disease, Chronic Obstructive/economics , Tiotropium Bromide/economics , Brazil , Drugs, Essential/economics , Health Services Accessibility/economics , Health Services Accessibility/legislation & jurisprudence , Health Services Accessibility/trends , Health Services Needs and Demand/economics , Health Services Needs and Demand/trends , Humans , National Health Programs , Pulmonary Disease, Chronic Obstructive/drug therapy , Retrospective Studies , Statistics, Nonparametric , Time Factors
5.
Einstein (Säo Paulo) ; 18: eGS5129, 2020. tab
Article in English | LILACS | ID: biblio-1056069

ABSTRACT

ABSTRACT Objective: Economic evaluation of a scientific advisory program with the Public Defenders Office to mitigate the impacts of the judicialization on health in the municipality, as well as the implementation of an active follow-up program to monitor health outcomes arising from court demands. Methods: A two-step study, the first documental, retrospective, with data collection of lawsuits in the region of Barbalha (CE), Brazil, from 2013 to 2018, and the second stage, prospective and intervention, through mediation between the citizen and the Public Defenders Office, aiming to reduce the occurrence of the judicialization, and the monitoring of the health outcomes of the processes. The study adopted the Consolidated Health Economic Evaluation Reporting Standards protocol for economic health assessments. The data obtained from the processes were grouped and treated for characterization of the scenario. A comparison of the profile of the lawsuits in the period of 12 months before and after the installation of the program to delimit a complete fiscal cycle was carried out. Results: The advisory service promoted a decrease of 40% (p=0.01) in lawsuits. There was a 31% reduction in court costs (p=0.003), with medicines accounting for 33% of this amount. There was a decrease in inputs outside the Sistema Único de Saúde lists (27%; p=0.003), however there was no statistical difference among several demanding groups, suggesting an equanimous approach. Conclusion: Data from the initial survey were comparable to those reported in Brazil regarding the profile of judicial demands. In view of the scenario, the proposal proved feasible as a means to mitigate the costs of the judicialization through mediation. Finally, the initiative can serve as a model for adoption by municipalities that have characteristics similar to those presented in this study.


RESUMO Objetivo: Avaliação econômica de um programa de aconselhamento científico junto à defensoria pública para minimizar o impacto da judicialização da saúde no município, bem como da implementação de um programa de pesquisa ativa para monitorar os desfechos em saúde provenientes de demandas judiciais. Métodos: Estudo conduzido em duas etapas. A primeira foi documental, retrospectiva, e composta por dados coletados de processos judiciais de 2013 a 2018 da região de Barbalha, no estado do Ceará. A segunda etapa foi prospectiva e de intervenção, conduzida por meio da mediação entre o cidadão e a defensoria pública, com o objetivo de reduzir a ocorrência da judicialização e monitorar os resultados dos processos de saúde. O estudo adotou o protocolo para avaliações econômicas em saúde Roteiro para Relato de Estudos de Avaliação Econômica. Os dados obtidos foram agrupados e tratados para caracterização do cenário. Comparou-se o perfil dos processos no período de 12 meses antes e após a instalação do programa para delimitar ciclo fiscal completo. Resultados: O serviço de consultoria promoveu redução de 40% (p=0,01) nas ações judiciais. Além disso, observou-se redução de 31% nos custos judiciais (p=0,003) com a medicação sendo responsável por 33% desse valor. Observou-se redução no uso de insumos não constantes nas listas do Sistema Único de Saúde (27%; p=0,003), contudo, sem diferença estatística entre os grupos. Conclusão: Os dados desta pesquisa foram comparáveis aos já relatados em pesquisas brasileiras quanto ao perfil de demandas. A proposta mostrou-se viável como meio de mitigar os custos da judicialização por meio da mediação. Essa iniciativa pode servir como modelo para os municípios que possuem características similares às apresentadas em nosso estudo.


Subject(s)
Humans , Judicial Role , Health Services Accessibility/legislation & jurisprudence , Health Services Needs and Demand/legislation & jurisprudence , Socioeconomic Factors , Brazil , Retrospective Studies , Cities , Outcome Assessment, Health Care , Health Care Costs/legislation & jurisprudence , Health Services Accessibility/economics , Health Services Needs and Demand/economics , National Health Programs/legislation & jurisprudence
6.
Einstein (Säo Paulo) ; 18: eGS4442, 2020. tab, graf
Article in English | LILACS | ID: biblio-1039730

ABSTRACT

ABSTRACT Objective To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease. Methods We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center. Results Public interest civil action and ordinary procedures, among others, were the most common used by the patients to obtain the medicine. Two Health Centers in Paraná (Londrina and Umuarama) concentrated more than 50% of the actions. The most common specialty of physicians who prescribed (33.8%) was pulmonology. There is a small financial impact of tiotropium bromide on general costs with medicines of the Paraná State Drug Center. However, a significant individual financial impact was observed because one unit of the medicine represents 38% of the Brazilian minimum wage. Conclusion Our study highlights the need of incorporating this medicine in the class of long-acting anticholinergic bronchodilator in the Brazilian public health system.


RESUMO Objetivo Analisar as demandas judiciais do brometo de tiotrópio para tratar a doença pulmonar obstrutiva crônica. Métodos Foram considerados dados secundários dos sistemas gerenciais de assistência farmacêutica, disponibilizados pelo Centro de Medicamentos do Paraná. Resultados Ações civis públicas e ações ordinárias, de procedimento comum, entre outras, foram as mais praticadas pelos pacientes para obter o medicamento. Duas Regionais de Saúde do Paraná (Londrina e Umuarama) concentraram mais de 50% das ações. Quanto à especialidade dos médicos prescritores, 33,8% eram pneumologistas. Verificou-se discreto impacto financeiro do brometo de tiotrópio nos gastos gerais com medicamentos pelo Centro de Medicamentos do Paraná. Entretanto, também houve relevante impacto financeiro individual, pois uma unidade do medicamento consome 38% do salário mínimo. Conclusão O estudo aponta para a necessidade de incorporação deste medicamento da classe broncodilatadores anticolinérgicos de longa duração, no Sistema Único de Saúde.


Subject(s)
Humans , Bronchodilator Agents/economics , Drugs, Essential/supply & distribution , Pulmonary Disease, Chronic Obstructive/economics , Judicial Role , Tiotropium Bromide/economics , Health Services Needs and Demand/legislation & jurisprudence , Time Factors , Brazil , Retrospective Studies , Statistics, Nonparametric , Drugs, Essential/economics , Pulmonary Disease, Chronic Obstructive/drug therapy , Health Services Accessibility/economics , Health Services Accessibility/legislation & jurisprudence , Health Services Accessibility/trends , Health Services Needs and Demand/economics , Health Services Needs and Demand/trends , National Health Programs
7.
Eur J Prev Cardiol ; 26(11): 1131-1146, 2019 07.
Article in English | MEDLINE | ID: mdl-30782007

ABSTRACT

AIMS: The aims of this study were to establish cardiac rehabilitation availability and density, as well as the nature of programmes, and to compare these by European region (geoscheme) and with other high-income countries. METHODS: A survey was administered to cardiac rehabilitation programmes globally. Cardiac associations were engaged to facilitate programme identification. Density was computed using global burden of disease study ischaemic heart disease incidence estimates. Four high-income countries were selected for comparison (N = 790 programmes) to European data, and multilevel analyses were performed. RESULTS: Cardiac rehabilitation was available in 40/44 (90.9%) European countries. Data were collected in 37 (94.8% country response rate). A total of 455/1538 (29.6% response rate) programme respondents initiated the survey. Programme volumes (median 300) were greatest in western European countries, but overall were higher than in other high-income countries (P < 0.001). Across all Europe, there was on average only 1 CR spot per 7 IHD patients, with an unmet regional need of 3,449,460 spots annually. Most programmes were funded by social security (n = 25, 59.5%; with significant regional variation, P < 0.001), but in 72 (16.0%) patients paid some or all of the programme costs (or ∼18.5% of the ∼€150.0/programme) out of pocket. Guideline-indicated conditions were accepted in 70% or more of programmes (lower for stable coronary disease), with no regional variation. Programmes had a multidisciplinary team of 6.5 ± 3.0 staff (number and type varied regionally; and European programmes had more staff than other high-income countries), offering 8.5 ± 1.5/10 core components (consistent with other high-income countries) over 24.8 ± 26.0 hours (regional differences, P < 0.05). CONCLUSION: European cardiac rehabilitation capacity must be augmented. Where available, services were consistent with guidelines, but varied regionally.


Subject(s)
Cardiac Rehabilitation/economics , Delivery of Health Care, Integrated/economics , Health Care Costs , Health Services Accessibility/economics , Healthcare Disparities/economics , Heart Diseases/economics , Heart Diseases/rehabilitation , Income , Outcome and Process Assessment, Health Care/economics , Cross-Sectional Studies , Europe/epidemiology , Health Care Surveys , Health Expenditures , Health Services Needs and Demand/economics , Heart Diseases/diagnosis , Heart Diseases/epidemiology , Humans , Social Security/economics , Treatment Outcome
8.
Med Health Care Philos ; 22(1): 53-58, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29946900

ABSTRACT

Thirty years of debate have passed since the term "Rule of Rescue" has been introduced into medical ethics. Its main focus was on whether or why medical treatment for acute conditions should have priority over preventive measures irrespective of opportunity costs. Recent contributions, taking account of the widespread reluctance to accept purely efficiency-oriented prioritization approaches, advance another objection: Prioritizing treatment, they hold, discriminates against statistical lives. The reference to opportunity costs has also been renewed in a distinctly ethical fashion: It has been stipulated that favoring help for identifiable lives amounts to a lack of benevolence for one's fellow creatures. The present article argues against both objections. It suggests that the debate's focus on consequences (deaths or severe ill health) should be reoriented by asking which aspects of such states of affairs are actually attributable to a decision maker who judges within a specific situation of choice.


Subject(s)
Beneficence , Financing, Government/economics , Health Priorities/economics , Health Resources/economics , Rescue Work/economics , Resource Allocation/economics , Decision Making , Ethics, Medical , Financing, Government/ethics , Health Priorities/ethics , Health Resources/ethics , Health Services Needs and Demand/economics , Health Services Needs and Demand/ethics , Humans , National Health Programs/economics , Rescue Work/ethics , Resource Allocation/ethics
9.
Clin Interv Aging ; 13: 2083-2095, 2018.
Article in English | MEDLINE | ID: mdl-30425463

ABSTRACT

Current trends in health care delivery and management such as predictive and personalized health care incorporating information and communication technologies, home-based care, health prevention and promotion through patients' empowerment, care coordination, community health networks and governance represent exciting possibilities to dramatically improve health care. However, as a whole, current health care trends involve a fragmented and scattered array of practices and uncoordinated pilot projects. The present paper describes an innovative and integrated model incorporating and "assembling" best practices and projects of new innovations into an overarching health care system that can effectively address the multidimensional health care challenges related to aging patient especially with chronic health issues. The main goal of the proposed model is to address the emerging health care challenges of an aging population and stimulate improved cost-efficiency, effectiveness, and patients' well-being. The proposed home-based and community-centered Integrated Healthcare Management System may facilitate reaching the persons in their natural context, improving early detection, and preventing illnesses. The system allows simplifying the health care institutional structures through interorganizational coordination, increasing inclusiveness and extensiveness of health care delivery. As a consequence of such coordination and integration, future merging efforts of current health care approaches may provide feasible solutions that result in improved cost-efficiency of health care services and simultaneously increase the quality of life, in particular, by switching the center of gravity of health delivery to a close relationship of individuals in their communities, making best use of their personal and social resources, especially effective in health delivery for aging persons with complex chronic illnesses.


Subject(s)
Chronic Disease/therapy , Diffusion of Innovation , Health Services for the Aged/trends , Population Dynamics/trends , Aged , Austria , Chronic Disease/economics , Chronic Disease/epidemiology , Chronic Disease/prevention & control , Community Networks/economics , Community Networks/organization & administration , Community Networks/trends , Cost-Benefit Analysis/trends , Delivery of Health Care, Integrated/economics , Delivery of Health Care, Integrated/organization & administration , Delivery of Health Care, Integrated/trends , Forecasting , Health Services Needs and Demand/economics , Health Services Needs and Demand/organization & administration , Health Services Needs and Demand/trends , Health Services for the Aged/economics , Health Services for the Aged/organization & administration , Home Care Services/economics , Home Care Services/organization & administration , Home Care Services/trends , Humans , Patient-Centered Care/economics , Patient-Centered Care/organization & administration , Patient-Centered Care/trends , Pilot Projects , Quality of Life , Telemedicine/economics , Telemedicine/organization & administration , Telemedicine/trends
10.
J Health Econ ; 62: 147-164, 2018 11.
Article in English | MEDLINE | ID: mdl-30368033

ABSTRACT

Addressing early-life micronutrient deficiencies can improve short- and long-term outcomes. In most contexts, private supply chains will be key to effective and efficient preventative supplementation. With established vendors, we conducted a 60-week market trial for a food-based micronutrient supplement in rural Burkina Faso with randomized price and non-price treatments. Repeat purchases - critical for effective supplementation - are extremely price sensitive. Loyalty cards boost demand more than price discounts, particularly in non-poor households where the father is the cardholder. A small minority of households achieved sufficient supplementation for their children through purely retail distribution, suggesting the need for more creative public-private delivery platforms informed by insights into household demand persistence and heterogeneity.


Subject(s)
Dietary Supplements/economics , Micronutrients/therapeutic use , Burkina Faso , Child Nutrition Disorders/prevention & control , Child, Preschool , Commerce/economics , Commerce/statistics & numerical data , Dietary Supplements/statistics & numerical data , Dietary Supplements/supply & distribution , Family Characteristics , Female , Health Services Needs and Demand/economics , Health Services Needs and Demand/statistics & numerical data , Humans , Infant , Male , Micronutrients/economics , Models, Econometric , Socioeconomic Factors
13.
J Headache Pain ; 18(1): 53, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28474253

ABSTRACT

BACKGROUND: The Eurolight project assessed the impact of headache disorders in ten EU countries, using the same structured questionnaire but varying sampling methods. In Lithuania, sample selection employed methods in line with consensus recommendations for population-based burden-of-headache studies. METHODS: The survey was cross-sectional. We identified, from the Residents' Register Service, a sample of inhabitants of Kaunas city and surrounding Kaunas region reflecting age (in the range 18-65 years), gender and rural/urban distributions of Lithuania. Medical students called unannounced at their homes and conducted face-to-face interviews employing a structured questionnaire. RESULTS: Of 1137 people in the pre-identified sample, 573 (male 237 [41.4%], female 336 [58.6%]; mean age 40.9 ± 13.8 years) completed interviews (participation proportion: 50.4%). Gender-adjusted 1-year prevalences were: any headache 74.7%; migraine 18.8%; tension-type headache (TTH) 42.2%; all headache on ≥15 days/month 8.6%; probable medication-overuse headache (pMOH) 3.2%. Migraine (OR: 3.6) and pMOH (OR: 2.9) were associated with female gender. All headache types except TTH were associated with significantly diminished quality of life. Migraine caused a mean 4.5% loss in paid worktime per affected male and 3.5% per affected female. Lost per-person times due to TTH were much less, but to pMOH and other headache on ≥15 days/month much higher. Among the entire workforce, lost productivity to migraine was estimated at 0.7%, to TTH 0.3% and to pMOH or other headache on ≥15 days/month 0.5%. The total of 1.5% may translate directly into lost GDP. Alternative calculations based on headache yesterday (with little recall error) produced, for all headache, a corroborating 1.7%. Similar losses from household work would also drain the nation's economy. Our findings were comparable to those from earlier studies using similar methods in Russia and Georgia. CONCLUSIONS: The multiple burdens from headache in Lithuania indicate substantial ill-health and unmet need for health care. The heavy burdens on individuals are matched by heavy economic burden. Of particular concern is the high prevalence of headache on ≥15 days/month, seen also in Russia and Georgia. Health policy in Lithuania must heed WHO's advice that effective treatment of headache, clearly desirable for its health benefits, is also expected to be cost-saving.


Subject(s)
Cost of Illness , Headache Disorders/epidemiology , Health Policy , Health Services Needs and Demand , Population Surveillance , Public Health/methods , Adolescent , Adult , Aged , Cross-Sectional Studies , Europe/epidemiology , Female , Headache Disorders/economics , Headache Disorders/psychology , Health Policy/economics , Health Services Needs and Demand/economics , Humans , Lithuania/epidemiology , Male , Middle Aged , Population Surveillance/methods , Prevalence , Public Health/economics , Quality of Life/psychology , Random Allocation , Young Adult
14.
Int J Health Econ Manag ; 17(4): 433-451, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28500474

ABSTRACT

Current cost-based approach in measuring health care output does not allow decomposition of health care expenditure into price and output components. In this paper we propose an episode-based direction measurement method which closely resembles the concept of output in the system of national accounts. Using data from the Canadian Institute for Health Information, we calculate a quality unadjusted output index of the Canadian hospital sector for the periods 1996-2005. The result shows that total output increases at an average annual growth rate of 1.49%. We expect that with the quality adjustment the actual rate is higher. This is in contrast with the long-held assumption that health care productivity growth is zero. Our results provide key information on the ongoing health care policy debate.


Subject(s)
Commerce/methods , Costs and Cost Analysis/methods , Economics, Hospital/organization & administration , Health Care Sector/organization & administration , Canada , Cost-Benefit Analysis , Economics, Hospital/standards , Health Care Sector/economics , Health Care Sector/standards , Health Services Needs and Demand/economics , Humans , National Health Programs , Quality of Health Care/economics
15.
BMC Public Health ; 17(1): 224, 2017 02 28.
Article in English | MEDLINE | ID: mdl-28241872

ABSTRACT

BACKGROUND: Many low and middle income countries have developed community health strategies involving lay health workers, to complement and strengthen public health services. This study explores variations in costing parameters pertinent to deployment of community health volunteers across different contexts outlining considerations for costing program scale-up. METHODS: The study used quasi experimental study design and employed both quantitative and qualitative methods to explore community health unit implementation activities and costs and compare costs across purposively selected sites that differed socially, economically and ecologically. Data were collected from November 2010 to December 2013 through key informant interviews and focus group discussions. We interviewed 16 key informants (eight District community health strategy focal persons, eight frontline field officers), and eight focus group discussions (four with community health volunteers and four with community health committee) and 560 sets of monthly cost data. Cost data were tabulated using Microsoft Excel. Qualitative data were transcribed and coded using a content analysis framework. RESULTS: Four critical elements: attrition rates for community health volunteers, geography and population density, livelihood opportunity costs and benefits, and social opportunity benefits, drove cost variations across the three sites. Attrition rate was highest in peri-urban site where population is highly mobile and lowest in nomadic site. More households were covered by community health workers in the peri-urban area making per capita costs considerably less than in the nomadic settings where long distances had to be covered to reach sparsely distributed households. Livelihood opportunity costs for Community Health Volunteers were highest in nomadic setting, while peri-urban ones reported substantial employability benefits resulting from training. Social opportunity benefits were highest in rural site. CONCLUSIONS: Results show that costs of implementing community health strategy varied due to different area contextual factors in Kenya. This study identified four critical elements that drive cost variations: attrition rates for community health volunteers, geography and population density, livelihood opportunity costs and benefits, and social opportunity benefits. Health programme managers and policy-makers need to pay attention to details of contextual factors in costing for effective implementation of community health strategies.


Subject(s)
Community Health Planning/economics , Community Health Services/economics , Community Health Workers/economics , Health Services Needs and Demand/economics , Adult , Community Health Services/organization & administration , Community Health Workers/education , Delivery of Health Care, Integrated/economics , Female , Focus Groups , Health Services Research , Humans , Kenya , Program Evaluation , Public Health/economics
17.
Schmerz ; 30(4): 351-7, 2016 Aug.
Article in German | MEDLINE | ID: mdl-27402265

ABSTRACT

From the point of view of healthcare policies, improvement in pain care has been required for years; however, there is a great discrepancy between the current need for pain care and the actual provision by healthcare services. This article seeks to demonstrate that while healthcare policies are one of the critical factors involved, a variety of conceptual, diagnostic and therapeutic causes should also be taken into account. Firstly, considering that pain care is primarily concerned with the suffering of pain by patients, the focus lies with their conscious experience in order to define the patients' understanding of pain. Additionally, in this article current biomedical and psychosocial comprehension concerning chronic pain will be illustrated and why it is necessary to broaden our horizons in order to do justice to patients with chronic pain.


Subject(s)
Chronic Pain/psychology , Chronic Pain/therapy , Health Services Accessibility , Health Services Needs and Demand , Illness Behavior , Pain Management/psychology , Chronic Pain/economics , Combined Modality Therapy/economics , Combined Modality Therapy/psychology , Cost Control/economics , Culture , Germany , Health Policy/economics , Health Services Accessibility/economics , Health Services Needs and Demand/economics , Humans , National Health Programs/economics , Pain Management/economics , Politics , Quality of Life/psychology , Social Isolation
20.
Health Econ ; 25(11): 1372-1388, 2016 11.
Article in English | MEDLINE | ID: mdl-26201936

ABSTRACT

Evidence on the impact of user costs on healthcare demand in 'universal' public National Health Services (NHS) is scarce. The changes in copayments and in the regulation of the provision of free patient transportation, introduced in early 2012 in Portugal, provide a natural experiment to evaluate that impact. However, those changes in user costs were accompanied with changes in the criteria that determine which patients are exempt from copayments, implying that simple comparisons of user rates would be biased. In this paper, we develop a new methodology to evaluate the impact of increases in direct and indirect user costs on the demand for emergency services (ES) in the presence of compositional changes in co-payment exempt and non-exempt populations. Our results show that the increase in copayments did not have an effect in moderating ES demand by paying users, but we find significant effects of the change in transport regulation. Thus, our results support the conclusion that indirect costs may be more important than direct costs in determining healthcare demand in NHS-countries where copayments are small and wide exemption schemes are in place, especially for older patients. Copyright © 2015 John Wiley & Sons, Ltd.


Subject(s)
Costs and Cost Analysis , Emergency Service, Hospital/economics , Health Services Needs and Demand/economics , Hospitals , Transportation/economics , Health Expenditures , Humans , Models, Economic , National Health Programs , Portugal
SELECTION OF CITATIONS
SEARCH DETAIL